News and Trends 24 Oct 2022
Syncona to acquire Applied Genetic Technologies Corporation
Healthcare company Syncona Limited says its newly established portfolio company has agreed to acquire, by a tender offer, all outstanding…
Syncona
- Latest Posts
News and Trends 25 Apr 2022
Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs
The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from the investment firm Syncona. The…
News and Trends 17 Feb 2020
UK Biotech Closes €50M Series A for GPCR Drug Discovery
Oxford-based OMass Therapeutics has extended its Series A round by €33M to fund the spectrometry-assisted development of drugs targeting G…
News and Trends 26 Feb 2019
Immuno-oncology Biotech Raises €31M to Progress T-Cell Boosting Therapy
The Swiss biotech Anaveon closed a very respectable €31M (CHF35M) Series A fundraising round to help progress its T-cell boosting,…
ADVERTISEMENT
News and Trends 30 Jun 2017
€40M in Series C for a British Biotech Treating Blindness with Gene Therapy
NightstaRx has raised €39.5M that will go towards three clinical programs testing gene therapies for rare diseases that cause blindness. …
Best in Biotech 12 Apr 2016
18 of the Best European VCs for Biotech in 2016
As Genentech is celebrating its 40th Birthday, it is also the 40th birthday of Biotechnology and the 40th birthday of…
News and Trends 21 Mar 2016
CAR-T Startup Gets €51M from Top&New Investors
Autolus (UK) has secured over €51M in a recent series B round, led by the biggest Biotech VC in Europe…
News and Trends 14 Mar 2016
British Startup Raises Millions to Become the Illumina for Epigenetics
Cambridge Epigenetix (UK) wants to unlock the power of the Epigenome and become what Illumina is for NGS. And now,…
News and Trends 11 Nov 2015
Oxford’s Nightstar Gene Therapy for Blindness in Men Shines with $35M Fundraiser
Choroideremia is a rare X-linked recessive retinal disease which eventually leads to blindness. A series B funding round has landed…
News and Trends 13 Oct 2015
The Top 15 European Biotech VCs
Biotech wouldn't exist without Venture Capitalists. These investors bring the cash necessary to run clinical trials or conduct the scaling-up…
